Virar, India

Kamlesh Padiya

This inventor holds 1 USPTO granted patent. Top assignee: 4Sc Ag. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kamlesh Padiya. Retrieved from https://idiyas.com/inventor/kamlesh-padiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kamlesh Padiya: Innovator in Histone Deacetylase Inhibitors

Introduction

Kamlesh Padiya is a notable inventor based in Virar, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that serve as effective inhibitors of histone deacetylases.

Latest Patents

One of Kamlesh Padiya's key patents is titled "Tetrahydro-fused pyridines as histone deacetylase inhibitors." This patent describes compounds of formula (I), wherein ring D and ring E together form a fused ring system selected from formulas (II), (III), (IV), (V), (VI), and (VII). The salts of these compounds are recognized as novel and effective inhibitors of histone deacetylases.

Career Highlights

Kamlesh Padiya is currently employed at 4SC AG, a company that focuses on the development of innovative therapies for cancer and autoimmune diseases. His work at 4SC AG has allowed him to contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, Kamlesh has collaborated with esteemed colleagues, including Thomas Maier and Thomas Beckers. These collaborations have further enhanced his research and development efforts in the field of histone deacetylase inhibitors.

Conclusion

Kamlesh Padiya's innovative work in the development of histone deacetylase inhibitors showcases his dedication to advancing medicinal chemistry. His contributions are paving the way for new therapeutic options in the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…